Contraceptive failure and the progestogen-only pill
نویسندگان
چکیده
منابع مشابه
Contraceptive failure and the progestogen-only pill.
Contraceptive failure and the progestogen-only pill The case report by Chandler and Nash1 in this issue of the Journal is interesting and highlights the need for trials of hormonal contraceptive use to include obese women. The authors acknowledge that despite an apparent association between contraceptive failure and higher body weight in studies of a Norplant® prototype and a levonorgestrelrele...
متن کاملContraceptive failure and the progestogen-only pill: the issue of body weight.
©FSRH J Fam Plann Reprod Health Care 2010: 36(3) Case report In December 2008, a 33-year-old, para 2 gravida 4, Caucasian woman presented to the sexual and reproductive health (SRH) community clinic requesting termination of pregnancy (TOP). This was an unintended pregnancy and she had been taking the progestogen-only pill (POP) etynodiol diacetate 500 μg (Femulen®) one tablet a day. The origin...
متن کاملImproving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen.
BACKGROUND The safety and efficacy of the anti-progestogen Org 31710 in improving cycle control in healthy women using the desogestrel progestogen-only pill was investigated in this randomized, double-blind, placebo-controlled study. METHODS A total of 103 women using the 75 micro g desogestrel progestogen-only pill daily also received either 150 mg Org 31710 or placebo once every 28 days, st...
متن کاملProgestogen-only contraceptive use among breastfeeding women: a systematic review.
BACKGROUND Postpartum women need effective contraception. Concerns have been raised that use of progestogen-only contraceptives (POCs) may affect breastfeeding performance and infant health outcomes. OBJECTIVES We investigated the clinical outcomes of breastfeeding duration, initiation of supplemental feeding and weaning, as well as infant outcomes including infant growth, health and developm...
متن کاملA novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).
BACKGROUND The acceptability and continuation rate of oral contraceptive steroids are limited by unpredictable bleeding and the fear of long-term risks such as breast cancer. By inhibiting ovulation and by altering the receptivity of the endometrium, antagonists of progesterone, such as mifepristone, could be developed as estrogen-free novel contraceptives. METHODS Multicentre, double-blind, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Family Planning and Reproductive Health Care
سال: 2010
ISSN: 1471-1893
DOI: 10.1783/147118910791749362